A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

NCT06710470 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

833

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Deucravacitinib
DRUG: Systemic psoriasis medications
OTHER: No systemic medications

Sponsor

Bristol-Myers Squibb